IRRAS AB Stock OTC Markets
Equities
IRRA.F
SE0008321202
Medical Equipment, Supplies & Distribution
Sales 2023 * | 165M 15.55M 21.36M | Sales 2024 * | 249M 23.42M 32.18M | Capitalization | 182M 17.13M 23.53M |
---|---|---|---|---|---|
Net income 2023 * | -101M -9.52M -13.08M | Net income 2024 * | -29M -2.73M -3.75M | EV / Sales 2023 * | 2.38 x |
Net Debt 2023 * | 211M 19.86M 27.28M | Net Debt 2024 * | 258M 24.3M 33.38M | EV / Sales 2024 * | 1.77 x |
P/E ratio 2023 * |
-0.13
x | P/E ratio 2024 * |
-0.43
x | Employees | 47 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 3.55% |
Latest transcript on IRRAS AB
Managers | Title | Age | Since |
---|---|---|---|
Will Martin
CEO | Chief Executive Officer | 49 | 17-12-31 |
Griffen Stapp
DFI | Director of Finance/CFO | 38 | - |
Director/Board Member | 66 | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marios Fotiadis
CHM | Chairman | 51 | 11-12-31 |
Director/Board Member | 66 | 15-05-31 | |
Director/Board Member | 69 | 17-08-31 |
1st Jan change | Capi. | |
---|---|---|
+12.37% | 130B | |
-9.54% | 10.81B | |
-17.40% | 7.12B | |
+47.72% | 6.46B | |
-31.81% | 3.98B | |
+8.15% | 3.43B | |
-20.83% | 2.48B | |
-18.87% | 1.91B | |
-25.13% | 1.66B |